tiprankstipranks
Trending News
More News >
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
Hong Kong Market

Dawnrays Pharmaceutical Holdings Ltd. (2348) Financial Statements

Compare
3 Followers

Dawnrays Pharmaceutical Holdings Ltd. Financial Overview

Dawnrays Pharmaceutical Holdings Ltd.'s market cap is currently HK$1.86B. The company's EPS TTM is HK$0.408; its P/E ratio is 3.05; and it has a dividend yield of 4.84%. Dawnrays Pharmaceutical Holdings Ltd. is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.06B¥ 1.15B¥ 1.28B¥ 1.17B¥ 1.02B
Gross Profit¥ 577.63M¥ 641.52M¥ 766.68M¥ 675.36M¥ 545.55M
Operating Income¥ 367.91M¥ 431.38M¥ 410.03M¥ 380.76M¥ 320.50M
EBITDA¥ 280.49M¥ 498.94M¥ 505.19M¥ 433.89M¥ 395.71M
Net Income¥ 564.94M¥ 326.00M¥ 358.06M¥ 358.18M¥ 268.13M
Balance Sheet
Cash & Short-Term Investments¥ 1.37B¥ 1.07B¥ 1.08B¥ 830.22M¥ 962.12M
Total Assets¥ 4.01B¥ 3.62B¥ 3.67B¥ 3.34B¥ 2.90B
Total Debt¥ 34.72M¥ 120.53M¥ 8.41M¥ 23.52M¥ 2.95M
Net Debt¥ -1.12B¥ -785.30M¥ -803.27M¥ -554.22M¥ -728.04M
Total Liabilities¥ 682.61M¥ 763.42M¥ 1.02B¥ 941.70M¥ 720.14M
Stockholders' Equity¥ 3.32B¥ 2.85B¥ 2.64B¥ 2.38B¥ 2.17B
Cash Flow
Free Cash Flow¥ 44.58M¥ 126.39M¥ 229.90M¥ 80.07M¥ 163.80M
Operating Cash Flow¥ 220.20M¥ 338.40M¥ 434.27M¥ 393.14M¥ 302.90M
Investing Cash Flow¥ 0.00¥ -387.57M¥ -175.01M¥ -284.20M¥ 26.45M
Financing Cash Flow¥ 0.00¥ 2.07M¥ -92.70M¥ -129.75M¥ -327.70M
Currency in CNY

Dawnrays Pharmaceutical Holdings Ltd. Earnings and Revenue History

Dawnrays Pharmaceutical Holdings Ltd. Debt to Assets

Dawnrays Pharmaceutical Holdings Ltd. Cash Flow

Dawnrays Pharmaceutical Holdings Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis